1. No category

ERIC MILLER
PROFILE
Strong track record in traditional US commercial operations as well as complex marketing
environments (global, alliance management, and orphan drug). Experience includes strategic
planning for assets in mid and late-stage development, tactical support of established
blockbuster brand, commercial operations and market expansion planning for injectable
specialty biologic, and EU launch of first-to-market biotech device. Record of effective
interaction with prominent thought leaders, advocacy groups, sales forces, and affiliates.
WORK EXPERIENCE
5/2007 – Present
Optio Consulting, LLC
LLC Founder - Biotech Marketing Consultant
San Francisco, CA
12/2005 – 4/2007
InterMune Corp.
Brisbane, CA
Senior Director, Commercial Operations
Directed US commercial team preparing for the launch of two phase III products (biologic
and small molecule) in pulmonary/critical care market and supporting orphan drug for
primary immune disorder. Commercial team responsible for marketing, market research,
analytics, revenue/P&L, advocacy group relations, thought leader development, national
congress activity, and specialty pharmacy operations.
ƒ
Led commercial/marketing team to achieve national-level awards for advertorial and
national congress messages as well as patient materials.
ƒ
Initiated and led thought leader advisor and advocacy relationship program and nationallevel meetings to obtain feedback on commercial plans and support for market messages.
7/2004 – 12/2005
Director, Pulmonary and CGD Marketing
Led CGD (primary immune deficiency) marketing, managed partnership with Baxter
Healthcare for ATT biologic co-promotion, and conducted pulmonary market planning.
ƒ
Developed first corporate strategic marketing plan for pulmonary/critical care market
including health economics and corporate accounts/access and reimbursement planning.
ƒ
Created sales force materials, POA, and conducted training for 79 US representatives.
8/2002 – 7/2004
Cerus Corp.
Concord, CA; Brussels and Madrid
Associate Director, Marketing
Conducted US product planning and supported a global corporate partnership by guiding EU
commercialization of a DNA/RNA cross-linking pathogen safeguard technology for blood
products. Product combines pharmaceutical, biologic, and device technology.
ƒ
Represented Cerus in eleven-month assignment as marketing/alliance manager at Baxter
Healthcare EU headquarters to develop launch tactics and EU sales force operations.
ƒ
Managed multi-disciplinary team in the creation of target product profile for pathogen
inactivation disposable/device in development for blood plasma market.
SAN FRANCISCO, CALIFORNIA
MOBILE: (925) 324-5527, EMAIL: [email protected]
ERIC MILLER
(page 2)
6/2000 – 7/2002
Eli Lilly and Company
Indianapolis, IN
Marketing Associate II, New Product Planning
Conducted strategic global market planning for two compounds (phase II & III). Performed
global market segmentation, selected target markets, and positioned both compounds.
ƒ
Led a broadly skilled cross-functional team to author two comprehensive annual plans.
Market planning earned prestigious 2001 Lilly Individual Leadership Award – only five
recipients from among all NPP, product, and brand team marketers company-wide.
ƒ
Executed a six-week launch readiness and portfolio review of the German Affiliate that
shifted over $10 million to more profitable products. Recognized for, “valuable in-depth
analysis and quality presentations in a high-workload, high-pressure, deadline-driven environment.”
12/1998 – 6/2000
Marketing Associate, Prozac Product Team (Brand Management)
Coordinated global marketing communications for the largest blockbuster product in the
company portfolio. Oversaw EU public relations and US direct-to-patient internet marketing.
ƒ
Pioneered Internet marketing for Lilly as sole driver of consumer marketing/research
during the development of www.prozac.com. “Datamonitor considers Eli Lilly’s www.prozac.com
site to be the best provider of interactive consumer services among the CNS sites we surveyed.”(8/2000)
ƒ
Received team leader’s award for overhauling public relations for the EU. “Eric improved
PR operations with the global PR agency to the best level in the three year relationship with Lilly.”
7/1996 – 12/1998
Sales Representative
Atlanta, GA
Psychiatry and primary care territory. “Eric was the catalyst that turned around a traditionally lowperforming Lilly territory in Atlanta (bottom five percent) and drove it to the top five percent in the nation.”
4/1993 – 7/1996
SmithKline Beecham (GSK)
Columbia, SC
Senior Sales Representative
Promoted primarily CNS products in a mixed hospital/specialist urban/rural territory.
11/1992 – 4/1993
Ciba Geigy (Novartis)
Lynchburg, VA
Sales Representative
Sold NSAIDs, CV drugs, and HRT to primary care physicians and specialists.
9/1987 – 5/1992
United States Army
Germany and US Locations
Military Officer (Captain)
Successfully led organizations of up to 190 men and women to achieve the rank of Captain.
EDUCATION
„
„
„
Prof. Sequence, Biotechnology Business & Marketing
MS, Business Administration (MBA)
BA, Gov’t & Int’l Relations (honors)
UC Berkeley, 2006
Boston University, 1991
Univ. of Notre Dame, 1987
SAN FRANCISCO, CALIFORNIA
MOBILE: (925) 324-5527, EMAIL: [email protected]